GLYCATE: cost and payments to doctors
What Medicare Part D paid pharmacies for GLYCATE, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Intra-sana Laboratories?
Intra-sana Laboratories reported the most payments naming GLYCATE. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $629K
- Providers
- 3,592
- Transactions
- 10,510
- Average per transaction
- $60
The per-transaction average — $60 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,592 providers the average total is $175, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Intra-sana Laboratories | $629,316 | 100.0% |
Other products from Intra-sana Laboratories
The company that reported the most payments naming GLYCATE also reports against these.
- Reltone 400 Mg$740,347
- Reltone 200 Mg$740,097
- Reltone$250